Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ellie M. Wekking is active.

Publication


Featured researches published by Ellie M. Wekking.


Clinical Endocrinology | 2008

Polymorphisms in the brain‐specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients

Wendy M. van der Deure; Bente C. Appelhof; Robin P. Peeters; Wilmar M. Wiersinga; Ellie M. Wekking; Jochanan Huyser; Aart H. Schene; Jan G.P. Tijssen; Witte J. G. Hoogendijk; Theo J. Visser; Eric Fliers

Introduction  Some hypothyroid patients continue to have significant impairments in psychological well‐being, despite adequate treatment with levothyroxine (LT4). T4 transport across the blood–brain barrier is one of the crucial processes for thyroid hormone action in the brain. OATP1C1, a thyroid hormone transporter expressed at the blood–brain barrier, is considered to play a key role in delivering serum T4 to the brain.


Neurotoxicology | 2003

Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.

Moniek van Hout; Ben Schmand; Ellie M. Wekking; Gerard Hageman; Betto G. Deelman

Suboptimal performance during neuropsychological testing can seriously complicate assessment in behavioral neurotoxicology. We present data on the prevalence of suboptimal performance in a group of Dutch patients with suspected chronic toxic encephalopathy (CTE) after long-term occupational exposure to solvents. One hundred and forty-five subjects referred to one of two Dutch national assessment centers for CTE were administered the Amsterdam Short-Term Memory Test (ASTM) and the Test of Memory Malingering (TOMM), two tests specifically developed for the detection of suboptimal performance. For both tests, very cautious cut-off scores were chosen with a specificity of 99%. Results indicated that suboptimal performance appears to be a substantial problem in this group of patients with suspected CTE after long-term exposure to organic solvents. Only 54% of our subjects obtained normal scores on both tests of malingering, i.e. at or above cut-off score. The two tests seemed to measure the same concept in that nearly all the subjects with low TOMM scores also had low ASTM scores. However, a higher proportion of subjects scored below the cut-off on the ASTM than on the TOMM.


Psychotherapy and Psychosomatics | 1991

Daily Stressors and Systemic Lupus erythematosus: A Longitudinal Analysis – First Findings

Ellie M. Wekking; A.J.J.M. Vingerhoets; A.P. van Dam; J.C. Nossent; A.J.J.G. Swaak

Patients with systemic lupus erythematosus (SLE) and a comparison group of patients with rheumatoid arthritis (RA) completed the Dutch Everyday Problem Checklist and the Dutch Arthritis Impact Measurement Scale measuring physical and psychosocial aspects of illness. Both scales were completed 9 times at 6-week intervals. In addition several hematological and serological parameters were assayed. Analysis over several time points resulted in only weak correlations between the variables under study. The most remarkable finding of this study was that in SLE patients number and intensity of daily stressors are more strongly related to physical and psychosocial status than in RA patients.


Neurotoxicology | 2012

Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics

Evelien van Valen; Christoph van Thriel; Ritva Akila; Linda Nordling Nilson; Rita Bast-Pettersen; Markku Sainio; Frank J. H. van Dijk; Gert van der Laan; Maarten M. Verberk; Ellie M. Wekking

INTRODUCTION The presence of neuropsychological impairment is a hallmark of chronic solvent-induced encephalopathy (CSE), and using clinical neuropsychological procedures to generate a valid assessment of the condition is crucial for its diagnosis. The goals of this consensus document are to provide updated knowledge of the neuropsychological characteristics of CSE and to provide internationally acceptable guidelines for using neuropsychological assessments in the process of diagnosing patients who are suspected of having CSE. MATERIALS AND METHODS A European working group that was composed of experts in the field of the clinical diagnosis of CSE met at several round-table meetings and prepared this report. The first section of the consensus paper addresses a review of the relevant literature that was published between 1985 and March 2012. The second section addresses recommendations for the clinical neuropsychological assessment of patients who are suspected of having CSE. RESULTS The literature review indicates that the most common neuropsychological impairments in CSE patients are within the domains of attention, particularly the speed of information processing, memory, and motor performance. It appears that the influence of CSE on memory processes mainly involves immediate recall and generally involves verbal, visual and visuospatial material. In the second section, six recommendations are presented regarding important functional domains for the neuropsychological diagnostic process of CSE that relate to the evaluation of neuropsychological impairment, the assessment and evaluation of symptoms, differential diagnostic considerations, the reliability and validity of neuropsychological test results, and the retesting of patients. DISCUSSION AND CONCLUSIONS These recommendations will contribute to the improvement of the process for accurately diagnosing CSE, better counselling for CSE patients, the comparability of epidemiological data between countries, and finally, by raising awareness, these recommendations will contribute to combating the adverse health effects of occupational exposure to solvents.


Journal of Affective Disorders | 2012

Cognitive functioning in euthymic recurrently depressed patients : Relationship with future relapses and prior course of disease

Ellie M. Wekking; Claudi Bockting; Maarten W. J. Koeter; Aart H. Schene

BACKGROUND Cognitive impairment seems to persist during the euthymic phase of recurrent depression but its relationship with future relapses as with prior course of the disease has to be elucidated. The purpose of this study is to investigate the presence and prognostic value of cognitive dysfunctions for relapse in high risk euthymic patients and to identify relevant associations between cognitive functioning and prior course of illness. METHODS Standardized neuropsychological tests of mental speed, memory and executive functioning were assessed in 137 remitted patients and compared with clinically used published normative data. Previous episodes and relapses within 24 months were measured using the Structured Clinical Interview for DSM-IV. RESULTS Cognitive performance was significantly impaired on 12 of the 14 variables indicating deficits in the domain of speed of information processing and memory. With Cox regression no significant neuropsychological predictors for relapse or recurrence were identified. Furthermore, Pearson correlations between neuropsychological test scores and number of previous episodes, residual depressive symptoms and duration of remission were non-significant. Later age of onset was correlated with a slower speed of information processing and lower verbal memory performance. LIMITATIONS Published test reference data were used but no healthy control group. CONCLUSION Presence of mild cognitive impairment in remitted patients was demonstrated but did not predict future relapses nor was it related with prior course of disease except for age of onset. Though, mild cognitive impairment after remission might have an impact on the quality of life, adding techniques from cognitive rehabilitation might prove to be a treatment option.


Psychotherapy and Psychosomatics | 2008

Psychosocial and cognitive rehabilitation of patients with solvent-induced chronic toxic encephalopathy: A randomised controlled study

Moniek van Hout; Ellie M. Wekking; Ina J. Berg; Betto G. Deelman

Background: There is little experience with the (neuro) psychological treatment of patients with solvent-induced chronic toxic encephalopathy (CSE). In this randomised controlled trial (RCT), a treatment programme was evaluated based on previous outcome studies of patients with chronic fatigue, whiplash and traumatic brain damage. Methods: The treatment consisted of 8 group sessions based on cognitive behavioural principles focusing on inadequate illness behaviours, and 8 sessions of cognitive strategy training to compensate memory problems. The research design was an RCT with follow-up, comparing the cumulative effect of the 2 interventions allocated in random order with a waiting-list control group. Outcome measures were treatment satisfaction, self-ratings of psychosocial and cognitive changes, psychosocial and memory questionnaires and neuropsychological tests. Multiple linear regression analyses were performed with baseline scores, treatment versus control condition, effort status, and litigation or financial compensation status as predictors. Results: Ninety-five patients started treatment, 84 patients had complete data. Treatment satisfaction was high. After the treatment, only the treatment group had improved on objective memory tests and on complaints related to CSE, but not on other questionnaires. Treatment effects diminished at follow-up. Insufficient effort and litigation were negatively associated with treatment outcome. Conclusions: The positive treatment effects on the cognitive tests were only temporary. It might be important to study the effect of booster sessions to update practiced cognitive strategies. Effort was an important predictor of success, more important than involvement in a litigation procedure. This finding should have implications for the selection of patients.


Psychotherapy and Psychosomatics | 2003

Psychological treatment of patients with chronic toxic encephalopathy: Lessons from studies of chronic fatigue and whiplash

Moniek van Hout; Ellie M. Wekking; Ina J. Berg; Betto G. Deelman

Background: Chronic toxic encephalopathy (CTE), which can result from long-term exposure to organic solvents, is characterized by problems of attention and memory, fatigue and affective symptoms. There is little experience with (neuro)psychological treatment in this patient group. We reviewed treatment outcome studies of CTE and comparable syndromes, namely, chronic whiplash-associated disorder (WAD) and chronic fatigue syndrome (CFS), with a view to providing recommendations for the psychological treatment of patients with CTE. Methods: PubMed and PsychLIT were systematically searched and reference lists of retrieved articles were studied. The articles were classified according to study design and level of evidence. Results: The studies of CFS provided high-level evidence for the effectiveness of cognitive-behavior therapy (CBT) in challenging dysfunctional cognitions regarding the effectiveness of rest and in stimulating graded activity. The studies of WAD were methodologically weaker, and most evaluated a combination of CBT and graded activity training. There was some evidence that changing fatigue- or pain-related behaviors may result in cognitive improvement. Two uncontrolled studies of CTE evaluated cognitive rehabilitation techniques but yielded inconsistent findings. Conclusions: CBT techniques focusing on changing illness attributions and on stimulating graded activity might be useful for patients with CTE, diminishing fatigue-related problems of concentration and memory. Future studies should evaluate whether cognitive deficits of CTE patients as a result of neurotoxic effects of exposure should be treated by cognitive rehabilitation.


Journal of Clinical Psychology | 1993

Depression and assessment of intellectual functioning

William W. Hale; Peter Dingemans; Ellie M. Wekking; Evert Cornelissen

This study examined the relation between WAIS and Wilson predictor of premorbid intelligence scores of 27 depressed and 34 nondepressed psychiatric patients. No significant difference was found between the WAIS and Wilson predictor of premorbid intelligence scores nor between the Verbal and Performance IQs.


The Journal of Clinical Endocrinology and Metabolism | 2005

Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.

Bente C. Appelhof; Eric Fliers; Ellie M. Wekking; Aart H. Schene; Jochanan Huyser; Jan G.P. Tijssen; Erik Endert; Henk van Weert; Wilmar M. Wiersinga


The Journal of Clinical Endocrinology and Metabolism | 2005

Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′- triiodothyronine therapy

Bente C. Appelhof; Robin P. Peeters; Wilmar M. Wiersinga; Theo J. Visser; Ellie M. Wekking; Jochanan Huyser; Aart H. Schene; Jan G.P. Tijssen; Witte J. G. Hoogendijk; Eric Fliers

Collaboration


Dive into the Ellie M. Wekking's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ben Schmand

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aart H. Schene

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bente C. Appelhof

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Eric Fliers

University of Amsterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge